Children diagnosed with diffuse midline gliomas (DMG) have an extremely poor overall survival: 9–12 months from diagnosis with currently no curative treatment options.
European Journal of Cancer Real-time drug testing of paediatric diffuse midline glioma: The Zurich DIPG/DMG centre experience
Previous
Previous
Pediatric Neurosurgery Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas
Next
Next